What is the primary focus of treatment for patients with drug-induced gingival enlargement?

The primary focus of treatment for patients with drug-induced gingival enlargement often centers around medication adjustment. This approach aims to address the root cause of the gingival overgrowth, which is typically linked to the use of certain medications, such as anticonvulsants, calcium channel blockers, or some immunosuppressants. When patients discontinue or switch to alternative medications that do not contribute to gingival enlargement, it can lead to significant reduction or resolution of the gingival tissue overgrowth.

While oral prophylaxis and gingivectomy may provide symptomatic relief or management of existing gingival issues, they do not address the underlying cause associated with drug use. Antimicrobial therapy may be beneficial in managing associated plaque or infection, but it does not prevent or directly treat gum enlargement induced by medications. Therefore, the most effective treatment strategy focuses on modifying the patient's medication therapy to eliminate the problem at its source, leading to a more sustainable outcome.